U.S. Supreme Court Hears Arguments on Gene Patentability

On Monday, The U.S. Supreme Court began hearing oral arguments in the case against Myriad Genetics to decide whether a human gene can be patented. Myriad Genetics holds patents for two genes (BRCA1 and BRCA2) that are known to influence the risk of developing breast cancer and ovarian cancer.

Join Our Newsletter

Be the first to know about client news, new services, industry headlines and more!